Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans.
about
Herpes simplex virus latency-associated transcript is a stable intronA comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivationHuman herpes viruses latent infection in the nervous systemIdentification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT.Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbitsInduction of varicella zoster virus DNA replication in dissociated human trigeminal gangliaAnalysis of protein expression from within the region encoding the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Identification of B cells as a major site for cyprinid herpesvirus 3 latency.Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell cultureThe 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells.Human herpesvirus latency.Virus and cell RNAs expressed during Epstein-Barr virus replicationVaricella zoster virus latency.Chronic progressive deficits in neuron size, density and number in the trigeminal ganglia of mice latently infected with herpes simplex virus.Experimental investigation of herpes simplex virus latencyHigh prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patientsAnalysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structureA review of the molecular mechanism of HSV-1 latency.Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiologyEffect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo.Long-term promoter activity during herpes simplex virus latencyA major portion of the latent pseudorabies virus genome is transcribed in trigeminal ganglia of pigs.Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses.Cloning of the latency gene and the early protein 0 gene of pseudorabies virus.The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript.U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in cultureIdentification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virusHerpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons.The herpes simplex virus latency-associated transcript is spliced during the latent phase of infectionHuman herpesviruses: a consideration of the latent state.Chromatin control of herpes simplex virus lytic and latent infection.Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatmentRapid host immune response and viral dynamics in herpes simplex virus-2 infection.Herpes simplex virus type 1 modulates cellular gene expression during quiescent infection of neuronal cells.An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.
P2860
Q24564505-839C4C0F-4142-4446-982B-D0DDE8908081Q26996418-F2ADD26E-9B9D-4DA3-A7FA-1A83B928E4C1Q28297488-C5DAB3E4-7915-40E8-8078-1B68973F09C7Q33238462-5EF2927B-CC30-4073-9DB2-BFF45E08DA9AQ33649139-0E99B624-0671-48B8-8F45-AE556E3922DFQ33778621-BBA56E48-9845-4108-B76F-0B58698C38DFQ33838578-49A923E2-AAA4-4DA6-8D32-C315D947D0E9Q33845198-00FCBFA1-6CD8-445D-B8F1-0867FCA35BCAQ33995747-0C0B4541-C3DA-4132-B8A0-125E9C180866Q34059245-F80BB2D8-A920-4B82-99B4-5F744536CE58Q34256311-0B5A8AA9-A3BD-4075-8EC7-BF3B919FCC49Q34357809-046F6055-E5F5-4E46-AC70-25239478F821Q34369555-33BAF636-A73D-4AF1-A179-8F7770B0F140Q34434702-597AB3AA-3AD3-4532-BE6B-EBC173C54412Q35054349-CEC71315-0D9C-4DDF-A047-2E35F39C7F87Q35074781-191409FF-887A-46BB-B01E-00DC9565DF45Q35374610-FADFDF95-6C51-424E-BCC3-38E65A655027Q35811381-4DF76010-8D25-4508-A7A1-2F64E261EE21Q35816869-FCB3CB5C-C459-4270-BBB8-D6C969E5DA42Q35877627-3832F7C4-9526-47AD-857F-D5108EDD4A44Q36408944-DF0C7C5D-74D6-4F88-AA3A-CF6428C71BBAQ36627016-35A21D30-BA5B-4D5D-923D-1284B0CC61C0Q36628425-E9CCF417-C914-4BDB-94E3-712C6EAE8241Q36634708-CA193076-F943-4BCF-B7B0-90596AB10135Q36636978-36FB0797-8531-4B3E-B8BF-5CCE3D2D350CQ36783846-8E56F853-9FCE-4947-A3C4-D70E5F3CC549Q36793283-D48F1873-2523-4CD6-AA49-95E56A2A6B77Q36793331-03275B63-C9D1-462E-B61B-83BBB0F0155CQ36798062-0392EAE2-B64F-4438-9030-3CA09E3EE865Q36798790-58E7B05F-6844-4DA8-8D44-751496953AF6Q36810970-B160F783-EFFA-4985-84F9-AEA168EF1FD4Q36830450-DA7D4F93-0DE5-4984-AED0-B0C4E802A29BQ36831283-71EFB651-97AD-4ACB-919A-3915C6D934F3Q36873719-FD5A183A-A567-4753-B128-8739C3775C27Q37055693-DFCC66EB-6887-45F9-A37D-FBE830004BD2Q37080840-4F262CAE-5ECD-4558-A579-FFF1BA8ED2F7Q37364727-DD6172AC-749B-49C6-A218-01781055D102Q37694574-4D7628AF-508C-43A6-ABDA-70E8C48CBFB2Q38513444-CB0A7FFC-3809-481B-9F3E-9F75CC963661Q38707911-593CE803-7465-4394-BB05-EBE05F8637E8
P2860
Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Prominence of the herpes simpl ...... glia from seropositive humans.
@en
Prominence of the herpes simpl ...... glia from seropositive humans.
@nl
type
label
Prominence of the herpes simpl ...... glia from seropositive humans.
@en
Prominence of the herpes simpl ...... glia from seropositive humans.
@nl
prefLabel
Prominence of the herpes simpl ...... glia from seropositive humans.
@en
Prominence of the herpes simpl ...... glia from seropositive humans.
@nl
P2093
P356
P1476
Prominence of the herpes simpl ...... glia from seropositive humans.
@en
P2093
P304
P356
10.1093/INFDIS/158.1.117
P407
P577
1988-07-01T00:00:00Z